ASI 2017* , ,
Presentations this author is a contributor to:
Preclinical characterisation of JAK1/JAK2 inhibitors for treatment of type 1 diabetes (#94)
11:00 AM
Helen E Thomas
Symposium V: Autoimmune and Inflammatory Diseases